Form 4: Teladoc Health Executive Arnnon Geshuri Reports Stock Transactions
SEC Form 4
Arnnon Geshuri, Chief People Officer of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units.
Summary
- On August 30, 2024, Arnnon Geshuri, the Chief People Officer of Teladoc Health, exercised performance stock units and restricted stock units, converting them into common stock.
- Geshuri acquired 977 shares through performance stock units, 1,179 shares through restricted stock units granted in 2022, and 2,867 shares through restricted stock units granted in 2023.
- On September 3, 2024, Geshuri sold 1,795 shares of common stock at a price of $7.164 per share.
- Following these transactions, Geshuri directly owns 44,914 shares of Teladoc Health common stock and holds derivative securities including 5,865 performance stock units, 2,359 restricted stock units from 2022, and 17,208 restricted stock units from 2023.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
- Employees holding similar stock units may be interested in the executive's actions.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| March 3, 2023 | Reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| March 1, 2024 | One-third of performance stock units vested. |
| August 30, 2024 | Exercise of performance stock units and restricted stock units. |
| September 3, 2024 | Sale of 1,795 shares of common stock. |
| September 4, 2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.